Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
04/2012
04/17/2012CA2347928C Cell surface molecule-induced macrophage activation
04/17/2012CA2177195C Method and composition for treating renal failure
04/13/2012CA2752372A1 Method for treating diabetes
04/12/2012WO2012048214A2 Use of hyaluronan for promoting angiogenesis
04/12/2012WO2012048125A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl trna synthetases
04/12/2012WO2012047948A1 New crystalline forms of the sodium salt of (4- {4- [5- ( 6 - trifluoromethyl - pyridin- 3 - ylamino ) - pyridin- 2 -yl] -phenyl} - cyclohexyl) -acetic acid
04/12/2012WO2012047871A1 Polymorphs of saxagliptin hydrochloride and processes for preparing them
04/12/2012WO2012047826A2 Methods of use of small molecule modulators of hepatocyte growth factor (scatter factor) activity
04/12/2012WO2012047800A1 Methods for increasing muscle glucose uptake and decreasing muscle recovery time using amino acid blend
04/12/2012WO2012047628A2 Methods of managing blood sugar levels and compositions related thereto
04/12/2012WO2012047495A2 Methods for preparing synthetic bile acids and compositions comprising the same
04/12/2012WO2012047172A1 Picropodophyllin monohydrate or polymorph a in cancer therapy
04/12/2012WO2012047171A1 Picropodophyllin polymorphs b or c for use in cancer therapy
04/12/2012WO2012046945A2 Pharmaceutical and food composition for preventing or treating diabetes or obesity
04/12/2012WO2012046869A1 Cyclic amide derivative
04/12/2012WO2012046792A1 Gpr119 agonist
04/12/2012WO2012046681A1 Agent for inhibiting expression of lipid metabolism related mrna
04/12/2012WO2012046249A1 Novel gpr 119 agonists
04/12/2012WO2012046062A1 Use of prodrugs to avoid gi mediated adverse events
04/12/2012WO2012045906A1 Polyhydroxylated aminocyclohexanes and use thereof for treating lysosomal diseases
04/12/2012WO2012045801A1 Lactoferrin based complex coacervates and their uses
04/12/2012WO2012045617A1 Peptides containing tryptophan
04/12/2012WO2012045400A1 An extract of the fruit of the plant schisandra chinensis
04/12/2012WO2012045363A1 Antidiabetic enolic glucoside of phenylpyruvic acid
04/12/2012WO2012031382A4 Special nutrient supplements for pregnant women
04/12/2012WO2012024584A3 Oxysterol compounds
04/12/2012WO2012024583A3 Oxysterol compounds
04/12/2012WO2012024581A3 Oxysterol compounds
04/12/2012WO2012023623A3 Agent for treatment of hunter syndrome
04/12/2012WO2011156820A9 Compositions, methods and uses for treatment of type 1 diabetes
04/12/2012WO2011153209A9 Cd36 inhibition to control obesity and insulin sensitivity
04/12/2012WO2011150030A9 Method to alleviate diabetic end stage renal disease
04/12/2012WO2011149950A3 Bicyclic heteroaryl kinase inhibitors and methods of use
04/12/2012WO2011126882A9 Therapeutic peptides and their derivatives and therapeutic uses thereof
04/12/2012US20120088840 Novel use of panduratin derivative or boesenbergia pandurata extract
04/12/2012US20120088830 Satiety-inducing composition
04/12/2012US20120088827 Oxabicyclo[4.1.0]Hept-B-en-S-yl Carbamoyl Derivatives Inhibiting The Nuclear Factor-Kappa (B) - (NF-KB)
04/12/2012US20120088825 Compounds with activity at estrogen receptors
04/12/2012US20120088817 Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
04/12/2012US20120088809 1-(2-alkyl-2,3-dihydro-benzofuran-4-yl)-pyrrolidin-3-ylamine acyl compounds
04/12/2012US20120088808 Crystal forms of saxagliptin
04/12/2012US20120088799 Serotonin reuptake inhibitors
04/12/2012US20120088788 Substituted imidazoles as bombesin receptor subtype-3 modulators
04/12/2012US20120088784 Substituted Aromatic Compounds and Pharmaceutical Uses thereof
04/12/2012US20120088783 Chroman derivatives
04/12/2012US20120088780 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
04/12/2012US20120088778 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
04/12/2012US20120088776 Treatment of mammalian disorders mediated by alpha-anhydrase isoforms
04/12/2012US20120088773 Circadian rhythm modulation
04/12/2012US20120088771 Tissue-nonspecific alkaline phosphatase (tnap): a therapeutic target for arterial calcification
04/12/2012US20120088762 Compounds for enzyme inhibition
04/12/2012US20120088760 Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient
04/12/2012US20120088751 Pharmaceutical compounds
04/12/2012US20120088749 S1P Receptor Modulating Compounds and Use Thereof
04/12/2012US20120088747 Sulfonamide containing compounds and uses thereof
04/12/2012US20120088746 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
04/12/2012US20120088742 Acetylsalicylic acid salts
04/12/2012US20120088741 Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase
04/12/2012US20120088729 Non-glycosylated transferrin expressed in monocots
04/12/2012US20120088720 Inhibitors of protein tyrosine phosphatases
04/12/2012US20120088716 Polypeptide Protracting Tags
04/12/2012US20120087997 Edible products with thermostatic and cognitive effects
04/12/2012US20120087985 Small peptide sequences for stabilizing biomolecules
04/12/2012US20120087925 Method for the treatment of inflammatory disorders
04/12/2012US20120087921 Novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer
04/12/2012US20120087920 Fgf21 mutants and uses thereof
04/12/2012US20120087919 Method for treating diabetes
04/12/2012US20120087912 Treatment methods using dkk-1 antibodies
04/12/2012US20120087896 Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and their use in bioassays
04/12/2012US20120087875 Buffered Gum Base For High PH Release
04/12/2012CA2822024A1 Use of hyaluronan for promoting angiogenesis
04/12/2012CA2813736A1 New crystalline forms of the sodium salt of (4- {4- [5- ( 6 - trifluoromethyl - pyridin- 3 - ylamino ) - pyridin- 2 -yl] -phenyl} - cyclohexyl) -acetic acid
04/12/2012CA2813719A1 Methods of use of small molecule modulators of hepatocyte growth factor (scatter factor) activity
04/12/2012CA2813639A1 Cyclic amide derivative
04/12/2012CA2813617A1 Antidiabetic enolic glucoside of phenylpyruvic acid
04/12/2012CA2812926A1 Picropodophyllin monohydrate or polymorph a in cancer therapy
04/12/2012CA2812921A1 Picropodophyllin polymorphs b or c for use in cancer therapy
04/12/2012CA2812795A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl trna synthetases
04/12/2012CA2812593A1 Alpha-ketoamide derivatives useful endothelial lipase inhibitors
04/11/2012EP2439270A1 Galactosidase derived from bacillus circulans
04/11/2012EP2439204A1 Heterocyclic compound and hematopoietic stem cell amplifier
04/11/2012EP2439202A1 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
04/11/2012EP2439198A2 Novel method for preparing rosuvastatin, intermediate compounds useful for preparing same, and method for preparing same
04/11/2012EP2439195A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof
04/11/2012EP2438927A1 Pharmaceutical composition, food or beverage, and methods for these products
04/11/2012EP2438923A1 Composition for preventing or treating obesity-related diseases mediated by the activation of ampk and including 2,5-bis-aryl-3,4-dimethyltetrahydrofuran lignans as active ingredients
04/11/2012EP2438169A1 Nucleic acid modulators of glycoprotein vi
04/11/2012EP2438051A1 L- ( piperidin-4-yl) -pyrazole derivatives as gpr 119 modulators
04/11/2012EP2438049A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
04/11/2012EP2438046A2 O-glcnac transferase inhibitors and uses thereof
04/11/2012EP2438043A1 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
04/11/2012EP2437771A2 Compositions and methods modulating mg29 for the treatment of diabetes
04/11/2012EP2437763A1 A novel antidiabetic furostanolic saponin rich (fsr) fraction from fenugreek seeds
04/11/2012EP2437745A1 Treatment of mammalian disorders mediated by alpha-carbonic anhydrase isoforms
04/11/2012EP2437732A1 Combination of dopamine agonists plus first phase insulin secretagouges for the treatment of metabolic disorders
04/11/2012EP2437600A1 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
04/11/2012EP2188253B8 Indol-2-one derivatives disubstituted in 3-position, preparation thereof and therapeutic use thereof
04/11/2012EP2062883B1 Catechin as insulin sensitivity improving agent
04/11/2012EP1891105B1 Oxyntomodulin analogues and their effects on feeding behaviour
04/11/2012EP1851205B1 Pyridazine derivatives and their use as therapeutic agents
1 ... 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 ... 1298